Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2020-06-23 Regulatory Filings
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Regulatory Filings Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 8096Q' and the concluding statement: 'This information is provided by RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', detailing changes in voting rights and share ownership thresholds crossed by a specific entity (Enterprise Ventures Limited/RisingStars Growth Fund II LP). This type of mandatory disclosure regarding significant changes in shareholding is a specific regulatory filing. While it relates to share ownership (which could sometimes overlap with other categories), the format and source strongly point to a general regulatory announcement category, which is best captured by RNS, as it is a direct notification disseminated via the RNS system.
2020-06-23 English
Notice of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Notice of AGM' and details the date and logistics for the 'Annual General Meeting ("AGM")'. This directly corresponds to the AGM Information category. Although it is a notice, the content is specifically about the AGM event itself, rather than just announcing the publication of the AGM notice document (which would lean towards RPA/RNS). Given the specific nature of the content focusing on the meeting arrangements, AGM-R is the most appropriate classification.
2020-06-19 English
Result of General Meeting and grant of warrants
AGM Information Classification · 1% confidence The document is an RNS announcement from N4 Pharma PLC, dated June 18, 2020. The primary content details the 'Result of General Meeting' including the voting outcomes for specific resolutions (all passed) and subsequent actions taken, such as the grant of warrants. This document reports the official results of a shareholder vote held at a general meeting. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is distributed via RNS, the specific content is about voting results, making DVA the most precise classification.
2020-06-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an RNS Number (2354Q) notification from Evgen Pharma PLC, dated June 17, 2020. The content is structured as a TR-1 form, which is a standard notification required under the Disclosure Guidance and Transparency Rules (DTR) when there is an acquisition or disposal of voting rights that crosses a threshold. This type of mandatory regulatory disclosure, especially when sourced from RNS (Regulatory News Service), falls under the category of general regulatory announcements. Since there is a specific category for 'Director's Dealing' (DIRS) and 'Major Shareholding Notification' (MRQ), I must evaluate which is the best fit. TR-1 forms specifically relate to changes in major interests in shares/voting rights. The definition for Major Shareholding Notification (MRQ) is 'Notification of changes in significant share ownership levels (crossing thresholds)'. This perfectly matches the content of the TR-1 form detailing the crossing of the 3% threshold by Enterprise Ventures Limited. Therefore, MRQ is the most precise classification.
2020-06-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an 'RNS Number' filing from the 'National Storage Mechanism'. The content is a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', detailing changes in voting rights and share ownership thresholds (crossing 7%). This type of mandatory disclosure regarding significant changes in shareholding by an entity (Enterprise Ventures Limited/RisingStars Growth Fund II LP) is a specific type of regulatory filing concerning ownership structure, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it is an RNS announcement, the specific content is a TR-1 form, which is a standard notification for major holdings, making MRQ more precise than the general RNS fallback.
2020-06-17 English
SFX-01 to be evaluated in COVID-19 trial
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 1520Q' and concludes with information stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is a system for disseminating regulatory announcements, typically used in the UK market. The content announces a significant development regarding the company's drug candidate (SFX-01) being selected for a COVID-19 trial, which constitutes material, non-public information requiring immediate disclosure. This type of general regulatory announcement that doesn't fit into specific categories like 10-K, ER, or DIV is best classified as a Regulatory Filing (RNS). The document length is moderate (5690 chars), but the structure and explicit RNS identifiers confirm its nature as a regulatory news release.
2020-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.